Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Liquidity (Details Narrative)

Liquidity (Details Narrative) - USD ($)						3 Months Ended
Liquidity (Details Narrative) - USD ($)	Mar. 30, 2017	Feb. 08, 2017	Jan. 25, 2017	Jan. 06, 2017	Dec. 22, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 23, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash and cash equivalents						$ 7,126,000	$ 4,340,000		$ 602,000	$ 8,310,000
Accounts receivable, net						2,265,000			2,209,000
Total current assets						10,659,000			4,240,000
Total current liabilities						13,024,000			$ 16,241,000
Net income (loss)						2,414,000	(4,786,000)
Net cash used in operating activities						4,149,000	3,970,000
Proceeds from issuance of sale of equity					$ 1,900,000	1,220,000
Proceeds from issuance of sale of equity, net					1,700,000
Secured debt					$ 1,330,000
Debt conversion, converted instrument, amount						4,222,000
Exchanged Convertible Note and the Senior Secured Convertible Note [Member]
Debt instrument, face amount								$ 3,550,000
Exchanged Convertible Note [Member]
Exchanged convertible note percentage	80.00%
Debt conversion, converted instrument, amount	$ 4,200,000
Debt conversion, converted instrument, shares issued	1,700,000
Exchanged New Convertible Note [Member] \| April 18, 2017 [Member]
Debt instrument, face amount	$ 3,550,000
Exchanged convertible note percentage	220.00%
Debt conversion, converted instrument, shares issued	1,600,000
Exchange Agreement [Member] \| Senior Secured Convertible Note [Member] \| April 18, 2017 [Member]
Debt instrument, face amount						3,550,000
Exchange Agreement [Member] \| Investor [Member] \| April 18, 2017 [Member]
Debt instrument, face amount						$ 3,550,000
Debt conversion, converted instrument, shares issued						3,800,000
RedPath Note [Member] \| Exchanged Convertible Note [Member]
Debt conversion, converted instrument, amount	$ 4,220,000
Debt conversion, converted instrument, shares issued	1,730,534
RedPath Note [Member] \| Investor [Member] \| Exchanged Convertible Note [Member]
Exchanged convertible note percentage	80.00%
RedPath Note [Member] \| Exchange Agreement [Member]
Debt instrument, face amount								9,340,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Senior Secured Convertible Note [Member]
Debt instrument, face amount								5,300,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Senior Secured Non-Convertible Note [Member]
Debt instrument, face amount								3,550,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Exchanged Non-Convertible Note” and “Exchanged Notes [Member]
Debt instrument, face amount								8,870,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Investor [Member]
Debt instrument, face amount								$ 8,900,000
Second Registered Direct Offering [Member]
Proceeds from issuance of sale of equity				$ 4,200,000
Number of common stock shares issued				630,000
Common stock issued price per share				$ 6.81
Third Registered Direct Offering [Member]
Number of common stock shares issued			855,000
Common stock issued price per share			$ 4.69
Warrant to purchase shares of common stock			855,000
Third Registered Direct Offering and Private Placement [Member]
Proceeds from issuance of sale of equity			$ 4,000,000
Settlement of obligation			$ 1,000,000
Confidentially Marketed Public Offering [Member]
Proceeds from issuance of sale of equity		$ 3,900,000
Number of common stock shares issued		1,200,000
Common stock issued price per share		$ 3.00
Percentage of additional option granted for underwriters		9.00%